We are pleased to announce that the clinical results of our HLA TGS kits developed by U-GEN’s subsidiary TBG (Xiamen), titled “Application of ONT in Ambiguous Results of the HLA-DPB1 Genotyping,” have been successfully published in the June 2024 issue (Vol. 26, No. 3) of the Journal of Clinical Transfusion and Laboratory Medicine. The research […]
↧